Our research into rare cancers

Help us beat cancer sooner


Our life-saving work relies on the money you give us.

Donate now and together we can save more lives by beating cancer sooner.


Donate now

Our research is saving lives

Together, rare cancers make up more than 20% of all cancer cases. We’ve contributed to several advances for people with rare cancers. We ran some of the first trials for people with uveal melanoma and neuroendocrine tumours, and showed that the drug Glivec was effective for some advanced gastro-intestinal stromal tumours (GIST). And we set up and continue to support the International Rare Cancers Initiative, which is developing clinical trials worldwide to find new treatments for rare cancers.

Rate this page:

Currently rated: 2.5 out of 5 based on 18 votes
Thank you!
We've recently made some changes to the site, tell us what you think